DHHS, NIH News  
 
 
National Institute on Drug Abuse (NIDA)

FOR IMMEDIATE RELEASE
Friday, September 8, 2006


Subscribe
  CONTACT:
Sara Rosario Wilson
301-443-6245

Contacto en Español:
301-594-6145

Save-the-Date, October 16-17, 2006
Drug Abuse Conference Scheduled in Seattle

NIDA to Host
“Blending Addiction Science & Practice: Bridges to the Future”
What: A two-day conference that will bring together clinicians and researchers to examine cutting-edge scientific findings about drug abuse and addiction and their application to clinical practice.
Why: A gap exists in the drug abuse treatment field between clinical practice and scientific research. This conference is part of an ongoing effort to bring the newest treatments to community practice.
Hosts: National Institute on Drug Abuse, National Institutes of Health Washington and Oregon/Hawaii Nodes of the National Drug Abuse Treatment Clinical Trials Network.
When: Monday and Tuesday, October 16 & 17, 2006

Where: Washington State Convention and Trade Center 800 Convention Place Seattle, Washington
Who Should Attend: Drug treatment counselors, social workers, healthcare providers, criminal justice staff, marriage and family counselors, public health workers, physicians, researchers interested in drug abuse and addiction issues, and the media are encouraged to attend.

Info: Blending Conference Overview

Plenary sessions will be presented by Nora D. Volkow, M.D., Director, National Institute on Drug Abuse (NIDA) and other experts in the field of drug abuse and addiction. The conference will include sessions on:

  • Sexual Risk Reduction Interventions for Substance Abuse Treatment Programs
  • Promoting Awareness of Motivational Incentives
  • What is Gender-Specific Treatment for Women?
  • Evidence-Based Treatment in Correctional Settings
  • Integrated Treatment for Trauma and Addiction-Seeking Safety
  • Managing Pain and Addiction in Diverse Treatment Settings

More details about the conference are available on NIDA’s website at http://www.drugabuse.gov.

Dr. Nora D. Volkow
Director, National Institute on Drug Abuse, National Institutes of Health

Dr. Nora D. Volkow was appointed Director of NIDA in May 2003. She is recognized as one of the world’s leading experts on drug addiction and brain imaging. Her work has been pivotal in demonstrating that drug addiction is a disease of the brain. She pioneered the use of brain imaging to investigate the toxic effects of drugs and the effects of drugs responsible for their addictive properties in the human brain. In addition, she has led important research in the areas of obesity, schizophrenia, aging, and ADHD. Dr. Volkow has published more than 330 peer-reviewed articles, more than 50 book chapters and non-peer-reviewed manuscripts, and also edited three books on the use of neuroimaging in studying mental and addictive disorders. A recipient of multiple awards, she was elected to membership in the Institute of Medicine, National Academy of Sciences, and was named “Innovator of the Year” in 2000 by U.S. News and World Report.

For more information or to arrange an interview with Dr. Volkow, please contact the NIDA Press Office at 301-443-6245. Dr. Volkow is bilingual and media interviews can be conducted in either English or Spanish.

The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to ensure the rapid dissemination of research information and its implementation in policy and practice. Fact sheets on the health effects of drugs of abuse and information on NIDA research and other activities can be found on the NIDA home page at http://www.drugabuse.gov

The National Institutes of Health (NIH) — The Nation's Medical Research Agency — includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.


NIH logo   Home > News & Events
Subscribe to receive future NIH news releases.